Preliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.

by Sandra Gordon

Potential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.

by Taneia Surles

‘Practice-changing’ research shows adding immunotherapy before and after surgery reduced recurrences for early-stage gastric cancer.

by Laura Gesualdi Gilmore

Participating in a structured exercise program after treatment was associated with a reduced risk of recurrence in people who had colon cancer.

by Sandra Gordon

A survey of head and neck cancer survivors reveals that many are not getting adequate survivorship care and may not even know it is available.

by Cameron Walker

From the Editor-in-Chief

Air pollution, both indoors and outdoors, is a leading cause of lung cancer, especially among nonsmokers.

by William G. Nelson, MD, PhD

Forward Look

Researchers explore adding immunotherapy before surgery to help improve outcomes for people with locally advanced disease.

by Risa Kerslake

Forward Look

A new type of T-cell therapy for a rare soft tissue cancer signals progress but also comes with risk.

by Christina Szalinski

Researchers explore the potential of immune checkpoint inhibitors before surgery to prevent recurrence in several cancers.

by Kendall K. Morgan

PSMA-targeted therapy, which delivers radiation directly to cancer cells, provides a new approach for those whose prostate cancer stops responding to other treatments.

by Stephen Ornes